KONEXAutomotive052960

3C Tae Yang

₩3,190 0.00%2026-11-18 close
Market Cap
₩15.6B
Turnover
₩3,190
Volume
1 shares
Shares out.
4.9M
PER
—
PBR
—
EPS
—
Dividend Yield
0.78%

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-11-18 close

01

Report overview

Harness Distribution, With a Medical-Device Option

3C TAE Yang is a KONEX-listed firm whose standalone sales are mostly automotive connector distribution, and its medical-device parts expansion is the main variable for any change in earnings structure.

  1. 1

    Disclosed standalone results for the 38th fiscal term (2025) show sales of KRW 73,389 million, operating profit of KRW 3,523 million and net income of KRW 2,578 million.

  2. 2

    In 2024, goods sold, mainly automotive connectors, made up 81.4% of standalone sales, and in-house manufactured products made up 18.6%.

  3. 3

    On October 26, 2026, the company said it signed a KRW 10 billion ultrasound catheter parts-and-equipment localization agreement with Siemens Healthineers and others.

  4. 4

    The year-end dividend is KRW 25 per share, disclosed at a 0.7% dividend yield.

  5. 5

    With a market capitalization of KRW 15.6 billion and traded value of only KRW 3,769,370, trading is very thin.

02

Business structure

3C TAE Yang traces its roots to Taeyang Sangsa, an automotive electrical parts distributor founded in 1983, and listed on KONEX in January 2023. Of 2024 standalone sales of KRW 71.9 billion, products accounted for KRW 13.3 billion (18.6%) and goods for KRW 58.6 billion (81.4%).

The product line centers on ultrasound probe harnesses built on micro coaxial cable, with Samsung Medison and Siemens Korea as main customers. Within goods sales, automotive wiring harness connectors account for 85.8%, semiconductor image sensors 9.8% and other items 4.4%.

The KONEX Checkpoint research report reads this as a distribution-based model that sources finished or semi-finished harnesses externally and delivers them to customers. In automotive connectors, many players compete, including Korea Electric Terminal (KET), TE Connectivity and HIROSE.

The global automotive wiring harness market is dominated by large Tier-1 suppliers such as Yazaki and Sumitomo Electric Industries.

Consolidated subsidiaries include Q-Intech (molds), Merit (office equipment), Taeyang Danja (electrical parts distribution) and Taeyang Robot Tech (learning devices), plus overseas entities in China, India and the United States.

Although classified under automotive, the company differs sharply in business model and scale from carmakers and large parts suppliers such as Hyundai Motor and Hyundai Mobis.

03

Recent trends

Disclosed standalone results for the 38th fiscal term (2025) show sales of KRW 73,389 million and operating profit of KRW 3,523 million. Net income was KRW 2,578 million, and earnings per share were less than one-fifth of the share price on March 31, 2026.

Standalone total assets were KRW 60,637 million, total liabilities KRW 19,380 million and total equity KRW 41,257 million.

On a consolidated basis, sales rose from KRW 60.0 billion in 2021 to KRW 62.7 billion in 2022, KRW 87.5 billion in 2023 and KRW 90.5 billion in 2024, while operating profit was KRW 2.1 billion, 3.6 billion, 2.9 billion and 3.1 billion respectively.

The board resolved on February 13, 2026 to pay a year-end cash dividend of KRW 25 per common share, with a record date of April 3, 2026. At the annual general meeting on March 31, 2026, all agenda items, including financial statement approval, an articles amendment and director appointments, were approved.

Of 4,887,078 total shares, 776,299 are treasury shares. Per a Hongcheon County notice, the company held a recruitment session on April 24, 2026 to hire 50 production staff because of facility expansion.

The share price was KRW 3,595 on March 31, 2026, and the 52-week range as of October 6, 2026 was KRW 2,900 to KRW 4,100. The October 27, 2026 close was KRW 3,200 (-2.88% from the prior day), and no verified figures for 2026 quarterly or half-year results were found, so none are described.

04

Outlook

According to an October 26, 2026 report, 3C TAE Yang signed a KRW 10 billion agreement with Siemens Healthineers, VALID and the Korea Evaluation Institute of Industrial Technology to localize core materials, parts and equipment for ultrasound catheters.

The company is to develop and test core parts such as ultrasound catheter sensors and cables, and to take part in cardiac catheter technology development and mass production. The agreement runs for two and a half years.

Because the project is at the R&D stage, the timing and size of any revenue contribution have not been confirmed. According to the KONEX Checkpoint report of April 23, 2025, the company was developing a disposable endoscope system and preparing for US FDA Class II clearance.

No later update on that approval process was verified. The same report notes that electric vehicles need roughly 1.5 to 2 times more wiring harness content than internal-combustion vehicles.

On the sector side, the 15% US auto tariff, applied retroactively from November 2025, removed part of the uncertainty, while a weak won is flagged as a cost burden for small parts makers.

Indicators to watch for 3C TAE Yang are the standalone operating margin, the share of in-house products in sales, and milestone results under the agreement.

05

Bull factors

Steady profitability and balance sheet

On a standalone basis, 2025 operating profit was KRW 3,523 million and net income was KRW 2,578 million. Total equity of KRW 41,257 million is more than double total liabilities of KRW 19,380 million.

In 2024, the company won the top management award at the KONEX Awards, with judges citing its consistently stable results. Dividend payments have continued, so the shareholder-return stance was maintained.

Expansion into higher-value medical products

The company has designed and manufactured micro coaxial cables for high-precision imaging since 1996. On that base, it supplies ultra-precise probe harnesses to high-end medical equipment makers such as Samsung Medison and Siemens Korea.

Through the October 2026 agreement, it is to take part in cardiac ultrasound catheter development and mass production, which offers a chance to extend its cable-assembly experience into a new product line.

Vehicle electrification and overseas footprint

Global Market Insights estimates the automotive wiring harness market at about USD 50 billion in 2023, growing at over 5% a year through 2030. The company has said it is setting up a new base in Mexico to target North America. It also sought to hire 50 production staff because of facility expansion.

These steps leave room to widen the sales base in operating terms, but actual results must be confirmed in later disclosures.

06

Bear factors

Distribution-heavy mix and thin margins

In 2024, goods made up 81.4% of standalone sales. The KONEX Checkpoint report noted that sales are large by KONEX standards but the operating margin stays in the low single digits, which it called weak on profitability.

The 2025 standalone operating profit of KRW 3,523 million is likewise a mid-single-digit share of sales of KRW 73,389 million. With such a high distribution share, profit can depend on procurement prices and supplier terms.

Limited growth visibility

The KONEX Checkpoint report forecast 2025 standalone sales of KRW 79.0 billion. Disclosed 2025 standalone sales of KRW 73,389 million came in below that forecast. In 2024, consolidated sales rose 3.5% to KRW 90.5 billion, but combined subsidiary sales fell 11.8%.

Because 2026 quarterly results were not verified, the basis for judging whether growth continues is also limited.

Uncertain commercialization of new businesses

The same report expected certification for the disposable endoscope to take roughly one to one and a half years. The catheter agreement likewise covers core parts development, performance testing and supply chain strengthening, which is an R&D-stage effort.

For both projects, the timing of any revenue contribution could vary with regulatory approval and customer adoption. A development cost burden arriving first cannot be ruled out.

07

Risk factors

Macro

The Korea Institute for Industrial Economics and Trade noted that the 15% US auto tariff removed uncertainty but that its impact passes through to parts suppliers as price-cutting pressure.

Others point out that a prolonged weak-won environment raises raw material and intermediate input costs and strains the liquidity of small parts makers. Because 3C TAE Yang relies heavily on externally sourced goods, exchange rates and carmaker conditions can affect purchase prices and demand. The company's actual currency sensitivity should be checked in its disclosure notes.

Industry and competition

The global harness and connector market is dominated by large Tier-1 suppliers. CEO Hwang Chang-soon said that even if most share goes to Chinese and Taiwanese firms, the company holds a competitive edge in high-value specialty wire module processing.

This can be read as the company acknowledging price competition in commodity segments. A distribution-centered business is also sensitive to changes in supplier terms.

Liquidity

Traded value on October 27, 2026 was only KRW 3,769,370. Given the structure of the KONEX market, even small orders can move the price sharply.

The KONEX Checkpoint report noted that market capitalization, in the high KRW 20 billion range just after listing, had settled at an average in the mid-KRW 10 billion range since the second half of 2024. The ownership structure, including 776,299 treasury shares, is also a factor in judging the tradable float.

08

Overall view

3C TAE Yang is a standalone-profitable company built on automotive connector distribution, with disclosed 2025 operating profit of KRW 3,523 million. Its balance sheet shows equity of more than twice liabilities, and dividends have continued.

On the other hand, goods account for a high share of sales and the operating margin stays in single digits, which analysts have flagged as a structural limit on profitability.

The KRW 10 billion ultrasound catheter agreement announced on October 26, 2026 is a clue to expansion in medical-device parts, but it is at the R&D stage and no earnings contribution has been confirmed.

Thin trading conditions, with a market capitalization of KRW 15.6 billion and traded value of KRW 3,769,370, also need to be weighed.

Because bullish and bearish factors coexist, quarterly results, the share of in-house products and milestone results under the agreement in follow-up disclosures would be the basis for any assessment. This report is provided for information only and is not investment advice.

09

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 11 more articles and sources
  1. m.news.nate.com
  2. news.nate.com
  3. mt.co.kr
  4. konex.or.kr
  5. news.mt.co.kr
  6. mt.co.kr
  7. theguru.co.kr
  8. gw.breaknews.com
  9. markets.hankyung.com
  10. kocham.org
  11. kaica.or.kr

Report written 2026-10-27 · Data as of 2026-10-26

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis